| Database ID | Symbol | Body Site | Sample Type | Sample Name | Microbe | Project ID | AS Type | Group | Chr | PSI Visulization | Splicing Variant | Details |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2095346 | TAF1C | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 16 | - |
PV=1 FDR=1 FC=-0.007 |
|
| 2095347 | TAF1C | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 16 | - |
PV=0.541 FDR=1 FC=-0.034 |
|
| 2095348 | PRDM15 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 21 | - |
PV=1 FDR=1 FC=-0.022 |
|
| 2095349 | PRDM15 | Blood | Tissue | PSC-derived alveolar epithelial type II-like cells | Control/Healthy;COVID-19 | GSE152418 | A3SS | G0/G1 | 21 | - |
PV=1 FDR=1 FC=-0.049 |
